{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T05:50:22Z","timestamp":1773208222593,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":2978,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.fertnstert.2013.12.050","type":"journal-article","created":{"date-parts":[[2014,2,4]],"date-time":"2014-02-04T01:30:36Z","timestamp":1391477436000},"page":"1123-1128.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study"],"prefix":"10.1016","volume":"101","author":[{"given":"Cem","family":"Celik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicel","family":"Tasdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remzi","family":"Abali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ercan","family":"Bastu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2013.12.050_bib1","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2013.12.050_bib2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2013.12.050_bib3","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2013.12.050_bib4","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/humrep\/16.9.1995","article-title":"Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome","volume":"16","author":"Norman","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.12.050_bib5","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1210\/jc.2004-1843","article-title":"Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study","volume":"90","author":"Legro","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2013.12.050_bib6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.fertnstert.2013.12.050_bib7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.fertnstert.2010.06.036","article-title":"Clinically useful predictors of conversion to abnormal glucose tolerance in women with polycystic ovary syndrome","volume":"95","author":"Pesant","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.12.050_bib8","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1093\/humrep\/der065","article-title":"Diabetes and impaired glucose tolerance in patients with polycystic ovary syndrome\u2014a long-term follow-up","volume":"26","author":"Hudecova","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.12.050_bib9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/bmj.39063.689375.55","article-title":"Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis","volume":"334","author":"Gillies","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2013.12.050_bib10","first-page":"126","article-title":"American Association of Clinical Endocrinologists. Position statement on metabolic and cardiovascular consequences of polycystic ovary syndrome","volume":"11","year":"2005","journal-title":"J Am Col Endocrinol"},{"key":"10.1016\/j.fertnstert.2013.12.050_bib11","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/AOG.0b013e3181bd12cb","article-title":"ACOG Practice Bulletin No. 108: Polycystic ovary syndrome","volume":"114","author":"ACOG","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2013.12.050_bib12","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2013.12.050_bib13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"ESHRE\/ASRM. Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Consensus on women's health aspects of polycystic ovary syndrome (PCOS)","volume":"97","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.12.050_bib14","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1093\/humrep\/det226","article-title":"Fasting glucose measurement as a potential first step screening for glucose metabolism abnormalities in women with anovulatory polycystic ovary syndrome","volume":"28","author":"Veltman-Verhulst","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.12.050_bib15","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1210\/jc.2007-1549","article-title":"Glucose intolerance in polycystic ovary syndrome\u2014a position statement of the Androgen Excess Society","volume":"92","author":"Salley","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2013.12.050_bib16","first-page":"19","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"8","author":"ESHRE\/ASRM. Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.12.050_bib17","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/humrep\/det002","article-title":"Assessment of impaired glucose tolerance prevalence with hemoglobin A(1)c and oral glucose tolerance test in 252 Turkish women with polycystic ovary syndrome: a prospective, controlled study","volume":"28","author":"Celik","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.12.050_bib18","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3109\/09513590.2013.774361","article-title":"The relationship between copper, homocysteine and early vascular disease in lean women with polycystic ovary syndrome","volume":"29","author":"Celik","year":"2013","journal-title":"J Intern Soc Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2013.12.050_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejogrb.2010.10.001","article-title":"Modified Ferriman-Gallwey hirsutism score and androgen levels in Turkish women","volume":"154","author":"Coskun","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"Suppl 1","key":"10.1016\/j.fertnstert.2013.12.050_bib20","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc10-S011","article-title":"Standards of medical care in diabetes\u20142010","volume":"33","author":"American Diabetes Association","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.fertnstert.2013.12.050_bib21","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.2337\/dc06-2461","article-title":"Population-based incidence of type 2 diabetes in northern Spain: the Asturias study","volume":"30","author":"Valdes","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.fertnstert.2013.12.050_bib22","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2337\/diacare.24.11.1941","article-title":"Reproducibility of the diagnosis of diabetes over a 30-month follow-up: the Paris prospective study","volume":"24","author":"Eschwege","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.fertnstert.2013.12.050_bib23","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJM198812083192302","article-title":"The natural history of impaired glucose tolerance in the Pima Indians","volume":"319","author":"Saad","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2013.12.050_bib24","first-page":"S9","article-title":"Impaired glucose tolerance\u2014prevalence and conversion to NIDDM","volume":"13","author":"Harris","year":"1996","journal-title":"J Br Diabet Assoc"},{"key":"10.1016\/j.fertnstert.2013.12.050_bib25","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.2337\/diabetes.54.4.1150","article-title":"Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program","volume":"54","author":"Knowler","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.fertnstert.2013.12.050_bib26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/dmrr.577","article-title":"Phenotypic and genetic clustering of diabetes and metabolic syndrome in Chinese families with type 2 diabetes mellitus","volume":"22","author":"Li","year":"2006","journal-title":"Diabetes\/Metab Res Rev"},{"key":"10.1016\/j.fertnstert.2013.12.050_bib27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1586\/eog.09.74","article-title":"Current procedures for managing polycystic ovary syndrome","volume":"5","author":"Massicotte","year":"2010","journal-title":"Exp Rev Obstet Gynecol"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028213034869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028213034869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:09:41Z","timestamp":1758010181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028213034869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0015028213034869"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2013.12.050","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2013.12.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}